Pharmacolog expands agreement with Codonics
Pharmacolog and Codonics extend existing agreement to include sales of DrugLog™ and associated services into GCC countries and Jordan.
Pharmacolog and Codonics is expanding their strategic agreement to now include Codonics distribution of DrugLog™ into Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, and Jordan. This makes Codonics the exclusive distributor of DrugLog™ in the U.S., Canada, and Middle East and WasteLog™ in the U.S., Mexico, China, and the Middle East. Less than one year ago, Pharmacolog and Codonics expanded their original agreement to include Codonics’ exclusive distribution of WasteLog™ into the Middle East.
DrugLog™ enables hospital pharmacies to implement additional quality control by verifying the identity and concentration of compounded injectable medications to ensure each drug is prepared accurately and safely prior to administration to a patient. Used as part of pharmacy’s in-house quality control process, DrugLog™ is ideal for chemotherapy and compounded medications whether patient-specific or batched. WasteLog™ enables a hospital pharmacy to analyze narcotic waste in seconds to help detect and deter drug diversion. When integrated with Codonics Safe Label System® (SLS), the drug assay workflow is automated by enabling a SLS-prepared syringe to be scanned into WasteLog™ to document important information about the drug. With either solution, user’s get highly accurate measurement results in <4 seconds with no machine contamination.
Timothy Jablonski, Codonics Vice President Marketing & International Sales, comments: “The latest amendment to our agreement with Codonics opens up yet another exciting market opportunity for DrugLog™ and enables us to offer an additional safety solution to our customers. We are passionate about our mission to improve patient safety and DrugLog™ enables us to continue on that path and bring industry-leading solutions to hospital pharmacies in the Middle East.”
Mats Högberg, CEO Pharmacolog comments: “This expansion of our collaboration with Codonics opens yet another exciting market opportunity for DrugLog™. As the Middle East healthcare providers follow US standards in many aspects, they also work purposefully to improve their medication safety, which includes the establishment of efficient procedures for quality control of prepared medication. The demand for effective and easy to use tools has therefore increased dramatically. Furthermore, Codonics has vast experience doing business in the Middle East with a substantial installed base. Launching together with Codonics provides us with access to this growing market immediately and will contribute to Pharmacolog’s continued growth.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.
Further information regarding the company is available at www.pharmacolog.com.
The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
